# Effect of Pioglitazone on Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus

> **NCT00232362** · PHASE1 · WITHDRAWN · sponsor: **Texas Tech University Health Sciences Center**

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Pioglitazone (Actos)
- **DRUG:** Anti-diabetic agent other than pioglitazone or rosiglitazone

## Key facts

- **NCT ID:** NCT00232362
- **Lead sponsor:** Texas Tech University Health Sciences Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-06
- **Primary completion:** —
- **Final completion:** 2008-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This study was not conducted as the Principal Investigator left the institution
- **Last updated:** 2015-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00232362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00232362, "Effect of Pioglitazone on Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00232362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*